Different origin-derived exosomes and their clinical advantages in cancer therapy

MLA

Xiaoyan Jin, et al. “Different Origin-Derived Exosomes and Their Clinical Advantages in Cancer Therapy.” Frontiers in Immunology, vol. 15, June 2024. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1401852.

APA

Xiaoyan Jin, Jing Zhang, Yufu Zhang, Jing He, Mingming Wang, Yu Hei, Shutong Guo, Xiangrong Xu, & Yusi Liu. (2024). Different origin-derived exosomes and their clinical advantages in cancer therapy. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1401852

Chicago

Xiaoyan Jin, Jing Zhang, Yufu Zhang, Jing He, Mingming Wang, Yu Hei, Shutong Guo, Xiangrong Xu, and Yusi Liu. 2024. “Different Origin-Derived Exosomes and Their Clinical Advantages in Cancer Therapy.” Frontiers in Immunology 15 (June). doi:10.3389/fimmu.2024.1401852.